FOLH1 and neoplasm: As revealed by these observations, the siFoxM1-Apt-CNBs are capable of doing specific detection of PSMA-expressing tumors, together with accumulation in tumor tissues, accordingly, thereby delivering more efficient treatment that is capable of inhibiting xenograft tumors.